Recombinant HGF, the ligand for Met, suppressed the progression in a mouse model of NASH, and MSP negatively regulated inflammation and lipogenesis in ex vivo models of NASH [54,106,107]. This evidence concerns the gene HGF and metabolic dysfunction-associated steatohepatitis.